Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Expert Opinion on Emerging Drugs
|
July 2, 2005
Caspase inhibitors as neuroprotective agents
J J Legos, D Lee, J A Erhardt
Zeitschrift Fur Gastroenterologie
|
February 26, 2000
[New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?]
W Petry, A Erhardt, T Heintges, et al.
Applied Optics
|
January 15, 1985
Reconstructing 3-D light-microscopic images by digital image processing
A Erhardt, G Zinser, D Komitowski, et al.
Biotechnology and Bioengineering
|
February 18, 2004
Hyperactivation of Rhizomucor miehei lipase by hydrophobic xerogels
Marc G Aucoin, Frank A Erhardt, Raymond L Legge
Clinical Pediatrics
|
February 28, 2002
Parental knowledge of and attitudes toward LYMErix (recombinant Osp--a lyme vaccine)
Stephen R Barone, Sarah S Bohrer, William A Erhardt
Deutsche Medizinische Wochenschrift (1946)
|
July 29, 2005
[Current treatment of hepatitis C virus infection]
J Lörke, A Avci, A Erhardt, et al.
European Journal of Clinical Investigation
|
April 1, 1989
Mobilizable lead in patients with chronic renal failure
J Koster, A Erhardt, M Stoeppler, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 1, 2000
[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]
A Erhardt, C Niederau, Y Osman, et al.
Drug Discovery Today
|
February 13, 2001
Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies
M E. Nuttall, D Lee, B McLaughlin, et al.
Journal of Endocrinological Investigation
|
April 1, 1979
Pituitary response to LHRH during the puerperium in women
W A Chamley, A Erhardt, D M deKretser, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Expert Opinion on Emerging Drugs
|
July 2, 2005
Caspase inhibitors as neuroprotective agents
J J Legos, D Lee, J A Erhardt
Zeitschrift Fur Gastroenterologie
|
February 26, 2000
[New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?]
W Petry, A Erhardt, T Heintges, et al.
Applied Optics
|
January 15, 1985
Reconstructing 3-D light-microscopic images by digital image processing
A Erhardt, G Zinser, D Komitowski, et al.
Biotechnology and Bioengineering
|
February 18, 2004
Hyperactivation of Rhizomucor miehei lipase by hydrophobic xerogels
Marc G Aucoin, Frank A Erhardt, Raymond L Legge
Clinical Pediatrics
|
February 28, 2002
Parental knowledge of and attitudes toward LYMErix (recombinant Osp--a lyme vaccine)
Stephen R Barone, Sarah S Bohrer, William A Erhardt
Deutsche Medizinische Wochenschrift (1946)
|
July 29, 2005
[Current treatment of hepatitis C virus infection]
J Lörke, A Avci, A Erhardt, et al.
European Journal of Clinical Investigation
|
April 1, 1989
Mobilizable lead in patients with chronic renal failure
J Koster, A Erhardt, M Stoeppler, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 1, 2000
[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]
A Erhardt, C Niederau, Y Osman, et al.
Drug Discovery Today
|
February 13, 2001
Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies
M E. Nuttall, D Lee, B McLaughlin, et al.
Journal of Endocrinological Investigation
|
April 1, 1979
Pituitary response to LHRH during the puerperium in women
W A Chamley, A Erhardt, D M deKretser, et al.
Page
of 11